Correlation Between Veritas Pharma and Painreform
Can any of the company-specific risk be diversified away by investing in both Veritas Pharma and Painreform at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veritas Pharma and Painreform into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veritas Pharma and Painreform, you can compare the effects of market volatilities on Veritas Pharma and Painreform and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veritas Pharma with a short position of Painreform. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veritas Pharma and Painreform.
Diversification Opportunities for Veritas Pharma and Painreform
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Veritas and Painreform is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Veritas Pharma and Painreform in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Painreform and Veritas Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veritas Pharma are associated (or correlated) with Painreform. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Painreform has no effect on the direction of Veritas Pharma i.e., Veritas Pharma and Painreform go up and down completely randomly.
Pair Corralation between Veritas Pharma and Painreform
If you would invest 498.00 in Painreform on September 5, 2024 and sell it today you would lose (213.00) from holding Painreform or give up 42.77% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 98.44% |
Values | Daily Returns |
Veritas Pharma vs. Painreform
Performance |
Timeline |
Veritas Pharma |
Painreform |
Veritas Pharma and Painreform Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Veritas Pharma and Painreform
The main advantage of trading using opposite Veritas Pharma and Painreform positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veritas Pharma position performs unexpectedly, Painreform can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Painreform will offset losses from the drop in Painreform's long position.Veritas Pharma vs. Cann American Corp | Veritas Pharma vs. Speakeasy Cannabis Club | Veritas Pharma vs. Benchmark Botanics | Veritas Pharma vs. Link Reservations |
Painreform vs. Regencell Bioscience Holdings | Painreform vs. Procaps Group SA | Painreform vs. Universe Pharmaceuticals | Painreform vs. Veritas Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |